SHP2 inhibition reduces somatotroph tumor growth in a pre-clinical model

García Barberá, F., Picech, F., Cecenarro, L., Mezger, G. F., Faure, E., Zlocowski, N., Calafat, P., De Battista, J. C., Mukdsi, J. H., Sosa, L. del V., & Petiti, J. P. (2025). SHP2 inhibition reduces somatotroph tumor growth in a pre-clinical model. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf057
Authors:
Facundo García Barberá
Florencia Picech
Laura Cecenarro
Gilda Florencia Mezger
Erica Faure
Natacha Zlocowski
Patricia Calafat
Juan Carlos De Battista
Jorge Humberto Mukdsi
Liliana Del Valle Sosa
Juan Pablo Petiti
Affiliated Authors:
Florencia Picech
Author Keywords:
shp2
sstr2
stat3
somatotroph tumor
Publication Type:
Article
Unique ID:
10.1093/neuonc/noaf057
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: